5,073
Views
58
CrossRef citations to date
0
Altmetric
PhD Summary

Preventing PTSD with oxytocin: effects of oxytocin administration on fear neurocircuitry and PTSD symptom development in recently trauma-exposed individuals

Article: 1302652 | Received 12 Feb 2017, Accepted 15 Feb 2017, Published online: 11 Apr 2017
 

ABSTRACT

Background: Posttraumatic stress disorder (PTSD) is a debilitating psychiatric disorder which develops in approximately 10% of trauma-exposed individuals. Currently, there are few early preventive interventions available for PTSD. Intranasal oxytocin administration early posttrauma may prevent PTSD symptom development, as oxytocin administration was previously found to beneficially impact neurobiological (e.g. amygdala reactivity) and socio-emotional PTSD vulnerability factors.

Objective: The overall aim of this dissertation was to investigate the potential of intranasal oxytocin administration as early preventive intervention for PTSD.

Methods: We performed a functional magnetic resonance imaging (fMRI) study to assess the acute effects of a single administration of oxytocin on the functional fear neurocircuitry – consisting of the amygdala and (pre)frontal brain regions – in recently trauma-exposed emergency department patients (range = 37–41). In addition, we performed a multicentre randomized double-blind placebo-controlled clinical trial (RCT) to assess the efficacy of repeated intranasal oxytocin administration early after trauma for preventing PTSD symptom development up to six months posttrauma (= 107).

Results: In our fMRI experiments we observed acutely increased amygdala reactivity to fearful faces and attenuated amygdala-ventromedial and ventrolateral prefrontal cortex functional connectivity after a single oxytocin administration in recently trauma-exposed individuals. However, in our RCT we found that repeated intranasal oxytocin administration early posttrauma reduced subsequent PTSD symptom development in recently trauma-exposed emergency department patients with high acute PTSD symptoms.

Conclusions: These findings indicate that repeated intranasal oxytocin is a promising early preventive intervention for PTSD for individuals at increased risk for PTSD due to high acute symptom severity. Administration frequency dependent effects of oxytocin or the effects of oxytocin administration on salience processing may serve as explanatory frameworks for the contrasting oxytocin effects on anxiety-related measures in our clinical and neuroimaging studies.

Highlights

  • Oxytocin administration may prevent posttraumatic stress disorder (PTSD) by affecting PTSD vulnerability factors (e.g. neural fear processing).

  • We investigated intranasal oxytocin effects on acute neural fear processing and subsequent PTSD symptoms in recently trauma-exposed individuals.

  • A single oxytocin administration increased neural fear processing.

  • Repeated oxytocin administration reduced PTSD symptoms up to six months posttrauma in participants with high acute PTSD symptoms, and is therefore a promising early preventive intervention for PTSD.

Disclosure statement

No potential conflict of interest was reported by the author.

Additional information

Funding

This work was supported by the Academic Medical Centre Research Council [110614]; ZonMw [91210041].